US Specialty Care Reaches the Finalist Round of the Patient Choice Awards for the Third Year in a Row

US Specialty Care, WellDyneRx’s wholly-owned specialty pharmacy, was named a finalist in the Annual Patient Choice Awards for a third year in a row. This award recognizes U.S. specialty pharmacies that provide best-in-class customer satisfaction and overall patient care, measured by the patient satisfaction ratings in the ZHI Specialty Pharmacy Patient Satisfaction Survey.

In 2017, US Specialty Care won the inaugural Patient Choice Award in the PBM/Payer Specialty Pharmacy category.

The pharmacy subsequently achieved finalist status in both 2018 and 2019. Nick Page, Chief Pharmacy Officer of WellDyneRx, said, “We’re honored to be named a finalist for the Patient Choice Awards again this year. Patient satisfaction is at the heart of everything we do because we know that it translates into increased engagement, higher adherence rates, and improved clinical outcomes. This, in turn, reduces costs for our clients.”

The Patient Choice Awards™ encompass 2 categories: the pharmacy benefit manager (PBM)/payer award and the nonPBM/payer award, both based on the average net promoter score from quarterly surveys conducted each calendar year. Unlike previous years where the awards ceremony was hosted during the Specialty Pharmacy Summit in Las Vegas, this year’s winner will be announced in the fall.


2019 Quarter Two WellInformed Table of Contents

Read the full Q2 2019 WellInformed Newsletter